{"transactions":[{"id":1833029,"issuer":{"id":6462,"kind":"organization","name":"Firy Inc.","symbol":"FIRY"},"owners":[{"id":111525,"kind":"person","name":"Ryu Elly","position":1,"cik":"0001860740","reported_name":"Ryu Elly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller/Head of Accounting"}}],"security":"Restricted Stock Units","published_at":"2023-07-07T16:20:39.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":5308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 23, 2023, the Issuer completed a 1-for-20 reverse stock split (the \"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock unit grant will vest on April 3, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock unit grant will vest on April 3, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 23, 2023, the Issuer completed a 1-for-20 reverse stock split (the \"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 23, 2023, the Issuer completed a 1-for-20 reverse stock split (the \"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."}],"balance_after":5308,"derivative":{"underlying":"Class A common stock","underlying_shares":5308},"source":{"system":"sec-edgar","filing":"0001860740-23-000005","document":"wf-form4_168876122944669.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860740/000186074023000005/wf-form4_168876122944669.xml","form_type":"4"}},{"id":1969408,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":111525,"kind":"person","name":"Ryu Elly","position":1,"cik":"0001860740","reported_name":"Ryu Elly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-06T20:44:49.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":17289,"price":0.587,"value":10148.643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of shares of common stock pursuant to a restricted stock unit award granted on February 18, 2022, which vested in connection the approval by Issuer's shareholders of the reverse merger transaction between the Issuer and Carisma Therapeutics, Inc. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person hereby undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at the price set forth above."}],"balance_after":148624,"source":{"system":"sec-edgar","filing":"0001485003-23-000108","document":"wf-form4_167815347664943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860740/000148500323000108/wf-form4_167815347664943.xml","form_type":"4"}},{"id":1996254,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":111525,"kind":"person","name":"Ryu Elly","position":1,"cik":"0001860740","reported_name":"Ryu Elly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-23T19:36:35.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":7159,"price":0.5873,"value":4204.4807,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of shares of common stock pursuant to a restricted stock unit award granted on February 18, 2022. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person hereby undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at the price set forth above."}],"balance_after":165913,"source":{"system":"sec-edgar","filing":"0001485003-23-000064","document":"wf-form4_167719898027733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860740/000148500323000064/wf-form4_167719898027733.xml","form_type":"4"}},{"id":2245155,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":111525,"kind":"person","name":"Ryu Elly","position":1,"cik":"0001860740","reported_name":"Ryu Elly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-03T19:22:36.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":95500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 1, 2022, the reporting person was awarded options to purchase 95,500 shares of the common stock of Sesen Bio, Inc. (the \"Company\"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vest date."}],"balance_after":95500,"derivative":{"exercise_price":0.5834,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":95500},"source":{"system":"sec-edgar","filing":"0001485003-22-000070","document":"wf-form4_165429852663606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860740/000148500322000070/wf-form4_165429852663606.xml","form_type":"4"}},{"id":2378997,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":111525,"kind":"person","name":"Ryu Elly","position":1,"cik":"0001860740","reported_name":"Ryu Elly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-23T20:37:05.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":86300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc.(the \"Company\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":86300,"source":{"system":"sec-edgar","filing":"0001485003-22-000021","document":"wf-form4_164566659718713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860740/000148500322000021/wf-form4_164566659718713.xml","form_type":"4"}},{"id":2552381,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":111525,"kind":"person","name":"Ryu Elly","position":1,"cik":"0001860740","reported_name":"Ryu Elly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2021-10-04T19:29:39.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in full on September 30, 2022, subject to recipient's continued employment through September 30, 2022. Each restricted stock unit represents a contingent right to receive one share of the Sesen Bio, Inc.'s common stock."}],"balance_after":126696,"source":{"system":"sec-edgar","filing":"0001485003-21-000196","document":"wf-form4_163339016370662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860740/000148500321000196/wf-form4_163339016370662.xml","form_type":"4"}}]}